Chronic hepatitis virus infection increases the risk of pancreatic cancer: A meta-analysis

Hepatobiliary and Pancreatic Diseases International

Volumn 12, Issue 6, 2013, Pages 575-583

  Xing, Shuai ^a,b   Li, Zhi Wei ^a   Tian, Yuan Feng ^a   Zhang, Li Min ^a,b   Li, Ming Qiang ^a,b   Zhou, Ping ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

HBV status; Hepatitis B virus; Hepatitis C virus; Meta analysis; Pancreatic cancer

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ALCOHOL CONSUMPTION; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER RISK; CHRONIC HEPATITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY HISTORY; HUMAN; META ANALYSIS; PANCREAS CANCER; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; TUMOR GROWTH;

FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 84896696204     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(13)60091-0     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Krechler T, Novotny J, Zeman M, Krska Z, Svestka T, Sváb J, et al. Pancreatic carcinoma and diabetes mellitus. Cas Lek Cesk 2004; 143: 97-100.
3. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009; 301: 2553-2562.
4. Liao KF, Lai SW, Li CI, Chen WC. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol 2012; 27: 709-713.
5. Boglione L, D'Avolio A, Cariti G, Gregori G, Burdino E, Baietto L, et al. Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D. Liver Int 2013; 33: 580-585.
6. Kim DY, Kim IH, Jeong SH, Cho YK, Lee JH, Jin YJ, et al. A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int 2013; 33: 586-594.
7. Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol 1984; 65: 651-655.
8. Katakura Y, Yotsuyanagi H, Hashizume K, Okuse C, Okuse N, Nishikawa K, et al. Pancreatic involvement in chronic viral hepatitis. World J Gastroenterol 2005; 11: 3508-3513.
9. Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB, et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2000; 6: 805-811.
10. Trepo CG, Zucherman AJ, Bird RC, Prince AM. The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol 1974; 27: 863-868.
11. Su FH, Chang SN, Chen PC, Sung FC, Su CT, Yeh CC. Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study. BMC Cancer 2011; 11: 495.
12. Zhou YM, Zhao YF, Li B, Huang JY, Wu LP, Xu DH, et al. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12: 289.
13. Ulcickas Yood M, Quesenberry CP Jr, Guo D, Caldwell C, Wells K, Shan J, et al. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection Hepatology 2007; 46: 107-112.
14. Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer 2012; 131: 461-468.
15. Lai SW, Liao KF. Hepatitis B and pancreatic cancer. Eur J Cancer Prev 2013; 22: 620.
16. Ben Q, Li Z, Liu C, Cai Q, Yuan Y, Wang K, et al. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China. Pancreas 2012; 41: 435-440.
17. Zhu F, Li HR, Du GN, Chen JH, Cai SR. Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China. Asian Pac J Cancer Prev 2011; 12: 1405-1408.
18. Xu P, Huang Q, Liu CH, Xie F, Shao F, Zhu CL, et al. Risk factors for pancreatic cancer: a case-control study. Tumor (Chinese) 2011; 31: 653-657.
19. Li HR, Lin TY. Hepatitis B virus infection in pancreatic cancer and lymphoma patients, comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy. Master's dissertation of Sun Yat-Sen University in Guangzhou (Chinese) 2010.
20. Hong SG, Kim JH, Lee YS, Yoon E, Lee HJ, Hwang JK, et al. The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study. Korean J Hepatol 2010; 16: 49-56.
21. Ma W, Xie DR, Cao WP, Yang Q, Jiang ZM, Chen DL, et al. Association between hepatitis B virus infection and pancreatic cancer. Chin J Clin Oncol (Chinese) 2009; 36: 1388-1390.
22. Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, et al. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int 2010; 30: 423-429.
23. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U. S. veterans. Hepatology 2009; 49: 116-123.
24. Berrington de Gonzalez A, Yun JE, Lee SY, Klein AP, Jee SH. Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev 2008; 17: 359-364.
25. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The New castle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses [serial online]. Accessed January 1, 2008. Available at http://www. ohri. ca/programs/clinical_epidemiology/oxford. asp.
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
27. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions [serial online]. Accessed March 1, 2011. Available from: http://www. mrc-bsu. cam. ac. uk/cochrane/handbook/.
28. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31.
29. U. de Bioestadística-Software: Meta-Disc. http://www. hrc. es/investigacion/metadisc_en. htm.
30. Yoshimura M, Sakurai I, Shimoda T, Abe K, Okano T, Shikata T. Detection of HBsAg in the pancreas. Acta Pathol Jpn 1981; 31: 711-717.
31. Taranto D, Carrato A, Romano M, Maio G, Izzo CM, Del Vecchio Blanco C. Mild pancreatic damage in acute viral hepatitis. Digestion 1989; 42: 93-97.
32. Raza S, Chaudhry NA, Brown JD, Aghaie S, Rezai D, Khan A, et al. To Study the Clinical, Biochemical and Radiological Features of Acute Pancreatitis in HIV and AIDS. J Clin Med Res 2013; 5: 12-17.
33. Hassan MM, Li D, El-Deeb AS, Wolff RA, Bondy ML, Davila M, et al. Association between hepatitis B virus and pancreatic cancer. J Clin Oncol 2008; 26: 4557-4562.
34. Fiorino S, Lorenzini S, Masetti M, Deleonardi G, Grondona AG, Silvestri T, et al. Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma. Med Hypotheses 2012; 79: 678-697.
35. Wang Y, Yang S, Song F, Cao S, Yin X, Xie J, et al. Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis. Eur J Cancer Prev 2013; 22: 328-334.
36. Luo G, Hao NB, Hu CJ, Yong X, Lü MH, Cheng BJ, et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis. Cancer Causes Control 2013; 24: 529-537.
37. Fiorino S, Chili E, Bacchi-Reggiani L, Masetti M, Deleonardi G, Grondona AG, et al. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis. Pancreatology 2013; 13: 147-160.